Company intelligence / Profile preview

MedEquity Capital

Waltham, Massachusetts, United States

Ownership: Private
Employees: ~5
Development stage: Other

Overview

MedEquity Capital is a private equity firm focused on investing in lower middle market healthcare businesses rather than developing therapeutics itself. The firm targets healthcare subsectors such as provider-based services, specialty pharmacy, outsourcing, distribution, technology-enabled services, and selected healthcare product businesses with relatively low technology risk. MedEquity emphasizes hands-on operating support alongside capital, drawing on partners with prior CEO and healthcare operating experience. Its portfolio has included companies in cardiovascular practice management, telepsychiatry, specialty pharmacy, urgent care, radiopharmacy, and other healthcare services niches. For biotech analysts, MedEquity is best understood as a healthcare-focused financial sponsor and operator-backed investor, not a drug-development company.

Industry: Investors

Beyond the preview

Go deeper on MedEquity Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedEquity Capital.

Explore the full profile